Volume 69 Received 26 December 2012 | ||||||||||
| ||||||||||
aDepartment of Physics, The Madura College, Madurai 625 011, India,bOrchid Chemicals & Pharmaceuticals Ltd, R&D Center, Chennai 600 119, India,cDepartment of Organic Chemistry, School of Chemistry, Madurai Kamaraj University, Madurai 625 021, India, and dDepartment of Food Science and Technology, University of Ruhuna, Mapalana, Kamburupitiya 81100, Sri Lanka
Correspondence e-mail: plakshmannilantha@ymail.com
In the title compound, C22H18FNO3S2, the five-membered thiazolidine ring is planar (r.m.s. deviation = 0.003 Å) and forms dihedral angles of 70.2 (3), 73.16 (17) and 10.32 (14)° with the cyclopropane, fluorobenzene and methylthiobenzene rings, respectively. The sum of the bond angles around the thiazolidine ring N atom (359.6°) indicates sp2 hybridization. The molecular structure features intramolecular C-H
S, C-H
F and C-H
O interactions. In the crystal, no significant intermolecular contacts were apparent.
For general properties of thiazolidines, see: Botti et al. (1996
); Spiegelman (1998
); Day (1999
); Barreca et al. (2002
).
|
|
| ||||||||||||||||||||||||||||||||
Data collection: APEX2 (Bruker, 2004
); cell refinement: SAINT (Bruker, 2004
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: PLATON (Spek, 2009
); software used to prepare material for publication: SHELXL97.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: TK5185 ).
SP thanks the management, Orchid Chemicals & Pharmaceuticals Ltd, Chennai, for providing laboratory facilities. JS thanks the UGC for the FIST support. JS and MV thank the management of The Madura College for their encouragement and support. RRK thanks the DST, New Delhi, for funds under the fast-track scheme (No·SR/FT/CS-073/2009).
Barreca, M. L., Balzarini, J., Chimirri, A., De Clercq, E., De Luca, L., Holtje, H. D., Holtje, M., Monforte, A. M., Monforte, P., Pannecouque, C., Rao, A. & Zappala, M. (2002). J. Med. Chem. 45, 5410-5413.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Botti, P., Pallin, T. D. & Tam, J. P. (1996). J. Am. Chem. Soc. 118, 10018-10024.
![[ISI]](../../../../../../logos/isiborder.gif)
Bruker (2004). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Day, C. (1999). Diabet. Med. 16, 179-192.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Spiegelman, B. M. (1998). Diabetes, 47, 507-514.
![[PubMed]](../../../../../../logos/pubmedborder.gif)